Trademark Search  /  GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,300 MG PER 130 ML (10 MG/ML)

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,300 MG PER 130 ML (10 MG/ML)

● Live · Registered

U.S. federal trademark · Serial No. 88125458 · Reg. No. 6200985

Mark
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,300 MG PER 130 ML (10 MG/ML)
Status
Registered
Serial Number
88125458
Registration No.
6200985
Filing Date
September 20, 2018
Registration Date
November 17, 2020
Class(es)
Class 005, Class 010

Owners

Sun Pharmaceutical Industries Limited
16 · Mumbai, Maharashtra, IN
Sun Pharmaceutical Industries Limited
16 · Mumbai, Maharashtra, IN
Sun Pharmaceutical Industries Limited
16 · Mumbai, Maharashtra, IN

Goods & Services

medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine

medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,300 MG PER 130 ML (10 MG/ML)" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.